Home > Financial Ratios > AJANTA PHARMA

AJANTA PHARMA
Core EBITDA Growth

    Back to All Ratios
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
AD     Remove this Ad

AJANTA PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 7.7642.48-15.611.9932.11

What is the latest Core EBITDA Growth ratio of AJANTA PHARMA ?

The latest Core EBITDA Growth ratio of AJANTA PHARMA is 7.76 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar20257.76
Mar202442.48
Mar2023-15.61
Mar20221.99
Mar202132.11

How is Core EBITDA Growth of AJANTA PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 7.76
-81.73
Mar2024 42.48
Positive
Mar2023 -15.61
Negative
Mar2022 1.99
-93.80
Mar2021 32.11 -

Other Financial Ratios of AJANTA PHARMA


Compare Core EBITDA Growth ratio of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹35,625.9 Cr 2.3% -0% 3.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


AJANTA PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

2.3%

-0%

3.5%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses